Arax Advisory Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13	Closed	-$1.37K	–	3135
2025 Q1	$1.37K	Sell	13 -30	-70%	-$3.16K	﹤0.01%	2203
2024 Q4	$4.61K	Hold	43	–	–	﹤0.01%	1768
2024 Q3	$4.3K	Hold	43	–	–	﹤0.01%	1779
2024 Q2	$3.62K	Buy	+43	New	+$3.62K	﹤0.01%	1727